New drugs in low-risk MDS: where do we stand?

Current Status

Not Enrolled

Price

Free

Get Started

Talha Badar

Dr. Badar is a Hematology and Oncology Faculty at Mayo Clinic, Florida. Dr. Badar’s research interest is in Acute Leukemia and Chronic Myeloid disorders. His current research focuses on studying genomic/immune profile of patients with high-risk leukemia and how to develop innovative treatment strategies to improve outcome. Dr. Badar is also actively involved in clinical trials in myeloid neoplasms that are being conducted at National and International level.

Course Content

New drugs in low-risk MDS: where do we stand?
Final Quiz